Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y T Tai

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Blood Cancer Journal|May 16, 2015
Rational combination treatment with histone deacetylase inhibitors and immunomodulatory drugs in multiple myelomaT Hideshima, F Cottini, H Ohguchi, et al.
Pacing and Clinical Electrophysiology : PACE|December 1, 1994
Rate adaptive cardiac pacing using right ventricular venous oxygen saturation: quantification of chronotropic behavior during daily activities and maximal exerciseC P Lau, Y T Tai, W H Leung, et al.
Blood|January 29, 2000
CD40 activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell linesG Teoh, Y T Tai, M Urashima, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damageY T Tai, G Teoh, B Lin, et al.
Oncogene|April 23, 2013
Targeting homologous recombination and telomerase in Barrett's adenocarcinoma: impact on telomere maintenance, genomic instability and tumor growthR Lu, J Pal, L Buon, et al.
Oncogene|July 27, 2007
A pivotal role for Mcl-1 in Bortezomib-induced apoptosisK Podar, S L Gouill, J Zhang, et al.
Oncogene|June 6, 2017
Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistanceY Song, S Li, A Ray, et al.
The Journal of Biological Chemistry|July 6, 2000
SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cellsD Chauhan, P Pandey, T Hideshima, et al.
Blood|December 9, 1998
Adenovirus vector-based purging of multiple myeloma cellsG Teoh, L Chen, M Urashima, et al.
Leukemia|March 25, 2015
Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myelomaS Kikuchi, R Suzuki, H Ohguchi, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Blood Cancer Journal|May 16, 2015
Rational combination treatment with histone deacetylase inhibitors and immunomodulatory drugs in multiple myelomaT Hideshima, F Cottini, H Ohguchi, et al.
Pacing and Clinical Electrophysiology : PACE|December 1, 1994
Rate adaptive cardiac pacing using right ventricular venous oxygen saturation: quantification of chronotropic behavior during daily activities and maximal exerciseC P Lau, Y T Tai, W H Leung, et al.
Blood|January 29, 2000
CD40 activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell linesG Teoh, Y T Tai, M Urashima, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damageY T Tai, G Teoh, B Lin, et al.
Oncogene|April 23, 2013
Targeting homologous recombination and telomerase in Barrett's adenocarcinoma: impact on telomere maintenance, genomic instability and tumor growthR Lu, J Pal, L Buon, et al.
Oncogene|July 27, 2007
A pivotal role for Mcl-1 in Bortezomib-induced apoptosisK Podar, S L Gouill, J Zhang, et al.
Oncogene|June 6, 2017
Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistanceY Song, S Li, A Ray, et al.
The Journal of Biological Chemistry|July 6, 2000
SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cellsD Chauhan, P Pandey, T Hideshima, et al.
Blood|December 9, 1998
Adenovirus vector-based purging of multiple myeloma cellsG Teoh, L Chen, M Urashima, et al.
Leukemia|March 25, 2015
Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myelomaS Kikuchi, R Suzuki, H Ohguchi, et al.
Pageof 14